Tylenol Ad Claim For Aspirin Users Should Not Imply NSAID Inferiority – NAD
This article was originally published in The Tan Sheet
An ad touting Extra Strength Tylenol as "doctor recommended" for patients on a low-dose aspirin regimen should be modified to exclude inferences that ibuprofen has a deleterious effect on aspirin's cardiovascular benefits, according to the National Advertising Division
You may also be interested in...
McNeil Consumer & Specialty Pharmaceuticals is running an ad campaign leveraging research indicating a potential risk in concomitant aspirin and nonsteroidal anti-inflammatory drug use
Bayer is cautioning consumers against the use of non-steroidal anti-inflammatory drugs in conjunction with aspirin use for heart health in a recently launched television ad campaign
Regular use of non-steroidal anti-inflammatory drugs may lessen the benefits of aspirin in reducing risk of myocardial infarction, a study recently published in Circulation says